Edition:
United States

Cardiovascular Systems Inc (CSII.OQ)

CSII.OQ on NASDAQ Stock Exchange Global Select Market

23.78USD
15 Dec 2017
Change (% chg)

$-0.95 (-3.84%)
Prev Close
$24.73
Open
$24.28
Day's High
$24.28
Day's Low
$23.23
Volume
366,525
Avg. Vol
85,320
52-wk High
$33.10
52-wk Low
$23.04

Latest Key Developments (Source: Significant Developments)

Cardiovascular Systems Inc reports Q1 loss per share $0.06
Wednesday, 25 Oct 2017 04:05pm EDT 

Oct 25 (Reuters) - Cardiovascular Systems Inc ::Cardiovascular Systems Inc reports fiscal 2018 first-quarter financial results.Q1 loss per share $0.06.Q1 revenue $49.7 million versus I/B/E/S view $51 million.Q1 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S.Sees Q2 2018 loss per share $0.03 to $0.06.Sees FY 2018 revenue $226 million to $233 million.Sees Q2 2018 revenue $52.5 million to $54 million.Q2 earnings per share view $-0.01, revenue view $55.1 million -- Thomson Reuters I/B/E/S.FY2018 revenue view $227.6 million -- Thomson Reuters I/B/E/S.  Full Article

Cardiovascular Systems announces anticipated revenue impact from hurricanes
Monday, 18 Sep 2017 07:00am EDT 

Sept 18 (Reuters) - Cardiovascular Systems Inc :Cardiovascular Systems announces anticipated revenue impact from hurricanes Harvey and Irma.Cardiovascular Systems - ‍impact of hurricanes Harvey and Irma on procedure volumes in Greater Houstonm Florida will reduce fiscal 2018 Q1 revenues​.Cardiovascular Systems -‍potential revenue impact on CSI quarterly results magnified due to "small product portfolio and location and timing of storms"​.Cardiovascular Systems - ‍fiscal Q1 revenues are more heavily weighted in September, as procedure volumes begin to accelerate from summer levels​.Cardiovascular Systems Inc - ‍"Houston and Florida markets typically generate over 15% of CSI's revenues"​.Cardiovascular Systems - ‍co anticipates that the factors will reduce Q1 revenues below range of $52.6 million to $53.6 million provided on August 2, 2017​.  Full Article

Cardiovascular Systems Q4 earnings per share $0.02
Wednesday, 2 Aug 2017 04:05pm EDT 

Aug 2 (Reuters) - Cardiovascular Systems Inc ::Cardiovascular Systems, Inc. Reports fiscal 2017 fourth-quarter financial results.Q4 earnings per share $0.02.Q4 revenue $52.9 million versus I/B/E/S view $52 million.Sees q1 2018 loss per share $0.07 to $0.09.Sees q1 2018 revenue $52.6 million to $53.6 million.Q4 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S.  Full Article

Brown Capital Management LLC reports 7.56 pct passive stake in Cardiovascular Systems
Monday, 10 Jul 2017 02:49pm EDT 

July 10 (Reuters) - Cardiovascular Systems Inc :Brown Capital Management LLC reports 7.56 percent passive stake in Cardiovascular Systems Inc as of June 30 - sec filing.  Full Article

Cardiovascular Systems says on June 27, Plaintiffs filed an amended complaint regarding Shoemaker V. Cardiovascular Systems case
Thursday, 29 Jun 2017 09:30am EDT 

June 29 (Reuters) - Cardiovascular Systems Inc :Cardiovascular Systems - On June 27, 2017, Plaintiffs filed an amended complaint regarding Shoemaker V. Cardiovascular Systems case.Cardiovascular Systems- ‍complaint makes allegations co made materially false, misleading statements,failed to disclose material adverse facts about business.Cardiovascular Systems - Plaintiffs seek unspecified monetary damages on behalf of alleged class, interest, attorney's fees and costs of litigation.Cardiovascular Systems Inc - Complaint relates to ‍alleged kickbacks to health care providers - SEC Filing​.  Full Article

Cardiovascular Systems Q3 loss per share $0.05
Wednesday, 3 May 2017 04:05pm EDT 

May 3 (Reuters) - Cardiovascular Systems Inc ::Cardiovascular Systems Inc reports fiscal 2017 third-quarter financial results.Q3 loss per share $0.05.Q3 revenue $52.1 million versus I/B/E/S view $51.1 million.Q3 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S.Sees q4 2017 loss per share $0.04 to $0.06.Sees q4 2017 revenue $51.5 million to $52.5 million.  Full Article

Cardiovascular Systems updates on former employee case
Wednesday, 26 Apr 2017 10:06am EDT 

April 26 (Reuters) - Cardiovascular Systems Inc :Cardiovascular Systems says jury awarded plaintiff $2.7 million compensatory damages for claims for whistleblower retaliation, wrongful termination.Cardiovascular Systems Inc - Case related to claims made by co's former regional sales manager.Cardiovascular Systems says jury also awarded plaintiff $22.4 million in punitive damages with respect to same claims.Cardiovascular Systems says it is assessing impact of the verdict on its financial results and condition and will provide further updates accordingly.  Full Article

Cardiovascular Systems initiates voluntary recall of saline infusion pump
Monday, 17 Apr 2017 09:15pm EDT 

April 17 (Reuters) - Cardiovascular Systems Inc :Cardiovascular Systems initiates voluntary recall of saline infusion pump.Cardiovascular Systems Inc - initiated a voluntary recall of its 7-10014 saline infusion pump.Cardiovascular Systems says csi expects to record approximately $1.5 million of expenses in its Q3 of fiscal 2017 related to recall and replacement.Says there have been no reports of patient injury to date.Cardiovascular Systems - recall and related charge do not have adverse effect on Q3 revenue and net loss guidance provided by company.Plans to recall and replace approximately 900 units of pumps currently in customer inventory.Cardiovascular Systems - determined electromagnetic interference present in hospital environment may cause pumps to switch to standby mode during use.  Full Article

Cardiovascular Systems receives approval for Diamondback 360 coronary orbital atherectomy system Micro Crown in the United States
Thursday, 30 Mar 2017 08:00am EDT 

Cardiovascular Systems Inc : Cardiovascular Systems, Inc. receives approval for the Diamondback 360® coronary orbital atherectomy system (oas) micro crown in the United States .A limited release of oas micro crown is expected to begin in U.S. later this summer.  Full Article

Cardiovascular Systems reports Q2 earnings per share $0.03
Wednesday, 25 Jan 2017 04:05pm EST 

Cardiovascular Systems Inc : Reports fiscal 2017 second-quarter financial results . Q2 earnings per share $0.03 . Q2 revenue $50 million versus I/B/E/S view $49.6 million . Sees Q3 2017 loss per share $0.04 to $0.06 . Sees Q3 2017 revenue $50.5 million to $51.5 million . Q2 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S .Q3 earnings per share view $-0.05, revenue view $51.9 million -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Cardiovascular Systems Inc reports Q1 loss per share $0.06

* Cardiovascular Systems Inc reports fiscal 2018 first-quarter financial results